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Abstract  
Aim: To case report the efficacy of subcutaneous steroid injections in the treatment of multiple 
chalazions and to evaluate the safety of intralesional injection in primary and recurrent chalazions in 
juvenile patient. 
Case report: A 25-year-old man noticed lesions which appeared on upper lid during past three 
months. It was clinically presented with three focal, large and painful nodules in upper right eyelid. 
Inflammation process began on May the 1st of 2013. After one month in May 30th 2013 was 
directly administered synthetic steroid, Kenalog-40. Application of triamcinolone acetonide resulted 
in two satellite lesions, compared to the original, when the same incisions drained during the first 
surgery in July 5th 2013, with topical antibiotic-steroidal drugs and hot compresses. Second surgery 
was in July 26th 2013. Third surgery was performed in August 5st 2013 with second application of 
Kenalog-40. Combined treatment leads to recovery of clinical signs and inflammation of right upper 
eyelid with regressions of primary and recurrent chalazions. 
Conclusion: Two steroid subcutaneous injections produced complete resolution of multiple primary 
and recurrent chalazions. Clinical imperative was that recurrent or unusual refractory chalazions 
require referral to Hystopathological examination of curetting to exclude malignancy.   
 
 
 
 
 
 
 
 
Introduction 
Chalazion is commonly benign as collection of 
chronic inflammatory lipogranulomatous tissue formed 
from meibomian glands which are lining the tarsus of 
the eyelid that is the site of pathology in a chalazion. 
Numerous meibomian glands located in the tarsus 
release an oily secretion that creates the precorneal 
tear film. Blepharitis or eyelid inflammation produces 
debris which can occlude meibomian gland orifices. 
There are two types of chalazion - external and 
internal, depending of localization in the eyelid. The 
main symptoms of chalazion include redness, swelling 
and swollen eyelids with painful and hard nodule [1].  
 Differential diagnosis of the eyelids pathology 
(for chalazion) include: pyogenic granuloma, 
lipogranuloma, papilloma of eyelid margin, focal blue 
nevus of eyelid, margin adenoid cystic carcinoma, 
margin sebaceous carcinoma, basso cell carcinoma, 
squamous cell carcinoma, etc [1]. 
 Chalazions often resolve spontaneously or 
respond to the conservative therapeutic regimen. 
Incision-drainage with triamcinolone acetonide 
suspension intralesional injections and worm 
compresses may be applied at home to promote 
faster recovery [2].  
 Referral to ophthalmologists for incision-
drainage and triamcinolone acetonide suspension 
injections - synthetic steroid (Kenalog-40) is primary 
used because of potent anti-inflammatory effects in 
disorders of eye system) is warranted for recurrent or 
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refractory chalazions. Dosage of Kenalog-40 is 
usually individualized, depending on the clinical 
pathology of eyelid and the patient's response to this 
treatment [2-8]. 
  Internal hordeola may harden into 
chalazions, and need referral for use Erythromycin, 
Trimethoprim/Sulfamethoxazole, Clindamycin or 
Cephalexin for two weeks as known oral regimen and 
controversial of this therapeutic module [9, 10]. 
  Malignancy must be ruled out in recurrent or 
refractory chalazions and because of that the tissue 
sample should be evaluated by the pathologists.  
 
Case report 
  A 25-year-old male presented with complaint 
of three mounts history of right eyelid redness, 
swelling and mild pain. 
  Personal and family history of our young 
patient suggests underlying conditions such as 
seborrhea dermatitis, rosacea and blepharitis without 
the atopic and the other organ-system diseases. 
Myopia in our patient and his young brother was 
corrected with soft contact lenses during last 11 years 
(as risk factor for chalazions). Intraocular pressure 
bilaterally was 15-16 mm Hg (by Goldman's 
tonometry) and visual acuity in both eyes was 20/20 
(by Snellen's test) remained stable before and after 
this treatment.  
 On examination, the superior portion of his 
right eyelid was erythematic and swollen, as well as 
warm and hard to palpation nodules (Figure 1).  
 
Figure1: Superior right eyelid - redness, swollen, hard nodules and 
linear perilesional hypo-pigmentation caused by Kenalog-40. 
There were no signs of consecutive 
conjunctivitis and scleritis. Inflammation process 
began in May 1
st 
2013, the disease started 
immediately and only after a few days of acute 
inflammation it expanded and closed whole upper 
right eyelid with pseudoptosis.  It was followed by 
incision-drainage one month after the disease started. 
In May 30
th
 2013 was directly administered synthetic 
steroid, Kenalog-40 (first dose of 20 mg) that resulted 
in two new, satellite lesions, compared to the original. 
After the first surgery in July 5
th
 2013, when the 
content of chalazions was drained trough incision on 
the inside of the right upper eyelid, with administrated 
antibiotic-steroidal topical therapy (sol. Ofloxacin, sol. 
Neodexacyn, unguent Chloramphenicol - four time per 
day) and worm compresses. The second same 
surgical intervention was performed in July 26
th
 2013. 
Third surgical intervention was performed in August 
5
st
 2013 with the second application of Kenalog-40 
(doses of 20 mg) and Ofloxacin therapy in duration of 
two weeks. Described multi-combined treatment (with 
infiltrative xylocaine - anesthesia) leads to recovery of 
clinical signs and inflammation of the right upper 
eyelid and the regression of his chalazions. Authors 
have expressed positive experiences as an innovation 
in surgical treatment of chalazions with topical 
application of iodine solution in the final curettage 
through the incision (several times) which has resulted 
in lessening the signs of local and consecutive 
inflammation.  
 The material obtained by a complete excision 
during the surgery was sent to histopathologic 
analysis immediately after. Hystopathological findings 
pointed to dominant granular-inflammatory and 
cellular composition in favor of recurrent chalazions, 
absence of cellular malignancy and the other clinical 
entities. The nodule consists of many types of immune 
cells, including connective tissue macrophages such 
as histiocytes, multinucleate giant cells (Langhan's 
type), plasma cells and polymorphonuclear leukocytes 
(Figure 2).  
 
Figure 2: Hystopathological result: inflammatory granulomatous 
lesions (giant-cells, lymphocytes, plasma-cells, histiocytes and 
polymorphonuclear leukocytes. 
  
There were no caused complications, such as 
subcutaneous atrophy, large skin depigmentation, 
skin necrosis, posterior subcapsular cataract and 
exophthalmos. The patient denied eye trauma, or eye 
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and systemic diseases that could cause consecutive 
disease. Some of the signs can be the localized loss 
of eyelashes in area of his recurrent chalazions, and 
that can be sign for his malignancies in this affected 
area.   
   
Discussion 
 Chronic inflammation leads to 
hyperkeratinization of ductal epithelium, which further 
obstructs the ducts. Chronic stagnation of meibomian 
secretion attracts bacteria that use lipids as nutritive 
substrate and releasing free fatty acids that can be 
toxic to the epithelium, which is well known 
biochemical process.   
 If chalazions don't resolve spontaneously, the 
instructions for patients is to apply a worm compress 
(3 to 5 minutes) to open the glands, then to digitally 
massages (either with fingers or cotton tips) the area 
to break and express the nodules, up to four times per 
day. If these procedures result to be ineffective, 
injections of triamcinolone acetonide (Kenalog-40) are 
to be applied directly into the chalazions. Approach 
the lesion from the palpebral side and inject 0.05 to 
0.3 ml in standard solution, using the insulin syringe. 
Two steroid injections produced a complete resolution 
of patient lesions - recurrent and refractory chalazions 
as the advantages in effective therapeutic module and 
without any drawbacks. The treatments for chalazions 
are incision and curettage technique (surgical 
extirpations) including removal of the pseudocapsule 
found surrounding the lesions and consists of a 
portion of the tarsal plate with fibroblastic scar tissue. 
Excision of the pseudocapsule, cosmetically cover a 
tumor and reducing the risk of re-accumulation of 
meibomian secretion in glands [1, 2].   
Many studies compare three methods of 
chalazion treatment: first - intralesional triamcinolone 
acetonide injections, second - incision and curettage, 
third - combination of incision, curettage and 
intralesional triamcinolone acetonide injections. After 
these treatments some patients have complained on 
recurrence or development of new lesions; other 
patients had yellow-white deposits at the site of 
transcutaneous injections. Procedures were 
comfortable and safe. Intralesional corticosteroid 
injection is especially effective for young patients. 
Incision and curettage are recommended for patients 
with multiple inflammations of chalazions because it 
was showed to prevent recidivate. Combined incision, 
curettage and intralesional steroid injection is the most 
effective approach for patients with large, recurrent 
and multiple chalazions in regression of recidivate [2], 
what we applied and was showed as useful in case of 
our young patient.  
Studies compare the outcome of intralesional 
corticosteroid injections and surgical treatment of 
chalazions. Intralesional steroid injections are 
effective and safe alternative to the other procedures 
for the treatment of chalazions. It is not associated 
with any serious complications, although skin 
depigmentation is relatively common in pigmented 
patients [3], which was not our case because our 
patient did not have dark skin.  
Other studies have reported the cases of 
patients with linear perilesional hypo-pigmentation and 
atrophy developed after intralesional injections of 
steroids used for the treatment of the keloids. The 
linear perilesional hypo-pigmentation is a distinct 
complication after intralesional application of steroids 
and it is probably due to lymphogenous spread of the 
steroid suspension [4]. In our case authors noticed 
discreet linear perilesional hypo-pigmentation as only 
skin complication mentioned to the treatment.  
Glucocorticoids are effective for the treatment 
of various inflammatory skin diseases, but their long-
term use may lead to serious side effects such as skin 
atrophy.  The Incidence of skin atrophies which 
following application of potent steroids is especially 
high in young patients. During last years the effects of 
Glucocorticoids on connective tissue have been 
clarified and the conclusion is that skin atrophy is 
mostly due to decrease in collagen synthesis. 
Collagen is the most contexture protein in the skin and 
the inhibition of its synthesis leads to skin atrophy. 
Many of studies explain the molecular mechanisms of 
steroid induced skin atrophy and validity of therapeutic 
possibilities [5]. We have not reviewed the cellular 
mechanisms of referred pathology because authors 
have not registered signs of eyelid skin atrophy.  
Ben Simon et al were evaluating the efficacy 
of intralesional triamcinolone acetonide injection in 
primary and recurrent chalazions in patients. Success 
was defined as at least an 80% decrease in size with 
no recurrence. If the lesion recurred or regression was 
minimal, less than 50%, further injections could be 
given as needed. If patients declined injection or did 
not respond to two or three injections must be referred 
for surgical excision and drainage. Most cases resolve 
with an average of one or two injections [6]. 
Triamcinolone acetonide may be considered as the 
first treatment in case where diagnosis is chalazion, 
which was confirmed in clinical case showed in this 
report.  
Many authors as Ben Simon GJ compare 
treatment outcomes of intralesional triamcinolone 
acetonide injection with incision-curettage for primary 
chalazion performed under local anesthesia which 
results in optimal multi therapeutic results with no 
recidivate and no pain [7].  
Norris JH says that the complete resolution 
was defined as lesion regression of 95-100%. 
Triamcinolone acetonide injections may be considered 
as alternative first-line treatment in cases where 
diagnosis is clear and no biopsy is required [8], whose 
opinion we also share.  
Chalazion surgery is a common minor 
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surgical procedure used to treat internal chalazions 
with minor and infrequent complications. The results 
of many clinical studies suggest that the use of 
thermal cauterization with surgery has no impact on 
the recurrence rate of internal chalazions. Use of 
thermal cauterization should be left to the decision of 
ophthalmologist [11]. 
Many clinical studies are analyzing modules 
of therapy for chalazion, such as Kenalog-40 injection, 
surgical incision-curettage, and use of the worm and 
dry compresses [12, 13], also used in our case.  
 Bârsan S et al have presented a clinical case 
of an infant with eye lid reconstruction after bilateral 
palpebral complete necrosis cussed by an extensive 
Pseudomonas aeruginosa infection. The substrate 
counterproductive evolution was identified by genetic 
analysis (X-linked Bruton-congenital agamma-
globulinemia) [9], which by now did not appear in our 
professional practice.  
Interesting study showed the efficacy and 
safety of subcutaneous Botulinum toxin A injections in 
the treatment of primary and recurrent chalazions with 
2-5 IU in 0.2-0.5 ml of preserved saline solution. 
Lesion regression that did not respond to the average 
of two injections, would benefit more from surgical 
excision or systemic antibiotic therapy [14], but 
authors do not have experience in using Botulinum 
toxin A in treatment of chalazions.  
Some studies have isolated and identified 
bacterial pathogens causing ocular infections and 
determined their in-vitro antibacterial sensitivity to 
commonly used antibacterial agents. Staphylococcus 
aureus is frequently causes infections of eyelids and 
internal hordeola. Of all routinely used antibacterial 
tested, flouroquinolones (gatifloxacin and ofloxacin) 
represented the choice for treatment of chalazions 
[10, 15], as was used on patient from this case report.  
As a conclusion, our patient with multiple 
chalazions was given intralesional injections of 
synthetic corticosteroid, Kenalog-40. Triamcinolone 
acetonide was given before and after surgical 
procedures that leads to success. Two steroid 
injections produced complete resolution of his 
recurrent and refractory lesions.  
Despite the availability of new topical options, 
minor surgical intervention will unfortunately continue 
to play a role in the long-term management of the 
anterior segment problems.  
The clinical imperative must be ruling out 
malignancy in recurrent and refractory chalazions and 
because of that the tissues sample should be 
evaluated by the pathologists. 
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